How has been the historical performance of Shilpa Medicare?

Nov 13 2025 11:29 PM IST
share
Share Via
Shilpa Medicare has shown significant growth in net sales and profitability, with net sales rising from 1,050.11 Cr in March 2023 to 1,286.41 Cr in March 2025, and profit after tax improving from a loss of 27.11 Cr to a profit of 79.57 Cr during the same period. The company's financial performance reflects resilience, despite fluctuations in raw material costs.
Answer:
The historical performance of Shilpa Medicare shows a significant upward trend in net sales and profitability over recent years, particularly in the fiscal year ending March 2025.

Breakdown:
Shilpa Medicare's net sales increased from 1,050.11 Cr in March 2023 to 1,286.41 Cr in March 2025, reflecting a strong growth trajectory. The total operating income followed a similar pattern, rising from 1,050.11 Cr in March 2023 to 1,286.41 Cr in March 2025. Despite fluctuations in raw material costs, which peaked at 424.80 Cr in March 2024, the company managed to maintain a healthy operating profit of 316.90 Cr in March 2025, up from 102.28 Cr in March 2023. The profit before tax also showed improvement, moving from a loss of 34.47 Cr in March 2023 to a profit of 123.60 Cr in March 2025. Consequently, the profit after tax turned positive, reaching 79.57 Cr in March 2025, compared to a loss of 27.11 Cr in March 2023. The company's total assets increased from 2,903.93 Cr in March 2023 to 3,297.74 Cr in March 2025, while total liabilities also rose, indicating a growing scale of operations. Cash flow from operating activities remained relatively stable, with a slight decrease to 132.00 Cr in March 2025 from 136.00 Cr in March 2024. Overall, Shilpa Medicare's financial performance demonstrates resilience and growth, particularly in sales and profitability metrics.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News